Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Blood Plasma Derivatives Global Market Report 2025
Request Sample Buy Now
Global Blood Plasma Derivatives Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Blood Plasma Derivatives Global Market Report 2025

By Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Other Types), By Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand's Disease, Other Applications), By End-User (Hospitals, Clinics, Other End-Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Blood Plasma Derivatives Market Overview

• Blood Plasma Derivatives market size has reached to $51.81 billion in 2024

• Expected to grow to $79.09 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%

• Growth Driver: Surging Demand For Blood Plasma Derivatives Driven By The Increasing Prevalence Of Immune Deficiency Disorders

• Market Trend: Strategic Partnerships In The Blood Plasma Derivatives Market For Enhancing Access And Supply For Immunoglobulins In France And Beyond

• North America was the largest region in 2024.

What Is Covered Under Blood Plasma Derivatives Market?

Blood plasma derivatives are medicinal products crafted from refined proteins found in blood plasma, encompassing clotting factors, albumins, and other proteins employed to treat diverse medical ailments. These derivatives hold significant significance as they aid in replenishing absent or inadequate proteins within the body.

The main types of blood plasma derivatives are albumin, factor VIII, factor IX, immunoglobulin, hyperimmune globulin, and others. Albumin refers to an essential protein present in blood plasma derivatives that aids in the regulation of osmotic pressure within the blood and facilitates the transportation of hormones, metals, and other molecules throughout the body. These are used in several applications, such as hemophilia, hypogammaglobulinemia, immunodeficiency diseases, von Willebrand's disease, and others, which are used by various end-users, including hospitals, clinics, and others.

Blood Plasma Derivatives Market Size and growth rate 2025 to 2029: Graph

What Is The Blood Plasma Derivatives Market Size 2025 And Growth Rate?

The blood plasma derivatives market size has grown strongly in recent years. It will grow from $51.81 billion in 2024 to $55.76 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to increased prevalence of hemophilia and bleeding disorders, growth in geriatric population, increased awareness and diagnosis, rise in surgical procedures, global blood transfusion services

What Is The Blood Plasma Derivatives Market Growth Forecast?

The blood plasma derivatives market size is expected to see strong growth in the next few years. It will grow to $79.09 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to emergence of rare diseases therapies, growth in chronic diseases, increasing healthcare expenditure, patient-centric treatment approaches, growing healthcare infrastructure. Major trends in the forecast period include advancements in fractionation technologies, patient-centric approaches, collaborations and partnerships, expanding applications in neurology, technological innovations in plasma fractionation.

The forecast of 9.1% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. patients by driving up the cost of immunoglobulin therapies and albumin solutions sourced from Austria and Spain, exacerbating treatment costs for immunodeficiencies and raising specialty pharmacy expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Blood Plasma Derivatives Market Segmented?

1) By Type: Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Other Types

2) By Application: Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand's Disease, Other Applications

3) By End-User: Hospitals, Clinics, Other End-Users

Subsegments:

1) By Albumin: Human Serum Albumin, Recombinant Albumin

2) By Factor VIII: Plasma-Derived Factor VIII, Recombinant Factor VIII

3) By Factor IX: Plasma-Derived Factor IX, Recombinant Factor IX

4) By Immunoglobulin: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)

5) By Hyperimmune Globulin: Specific Pathogen-Reduced Hyperimmune Globulin, Standard Hyperimmune Globulin

6) By Other Types: Fibrinogen, Clotting Factor Concentrates, Plasma-Derived Proteins

What Is Driving The Blood Plasma Derivatives Market? Surging Demand For Blood Plasma Derivatives Driven By The Increasing Prevalence Of Immune Deficiency Disorders

The increasing prevalence of immunodeficiency disorders is expected to drive the growth of the blood plasma derivatives market. Immunodeficiency disorders are illnesses that either completely or partially compromise the immune system. Blood plasma derivatives find application in treating a multitude of medical conditions, including immune deficiency disorders. Plasma, a solution consisting of proteins and salts, encompasses over 100 different proteins, among which immunoglobulins are particularly utilized for addressing primary immunodeficiencies. Poor nutrition or malnutrition leads to macro- and micronutrient deficiencies, which can lead to immunodeficiency. For instance, in March 2022, according to the Allergy, Asthma & Clinical Immunology, the most common condition was Common Variable Immunodeficiency (CVID), affecting 16.6% of individuals in the US, 12.9% internationally, and 13.9% worldwide. Therefore, the increasing prevalence of immune deficiency disorders is driving the growth of the blood plasma derivatives industry.

What Is Driving The Blood Plasma Derivatives Market? Impact Of Trauma And Accident Cases On The Surging Growth Of The Blood Plasma Derivatives Market

The rise in trauma and accident cases is expected to propel the growth of the blood plasma derivatives market going forward. Trauma and accident cases refer to situations where individuals experience physical injuries or harm as a result of an unexpected incident or event. Blood plasma derivatives are used in trauma and accident cases to replace clotting factors, treatment for hemorrhagic shock, to hemostasis and coagulation control, fluid replacement, wound healing support, and to manage edema and support fluid balance. For instance, in April 2024, according to the National Highway Traffic Safety Administration, a US-based government agency, in 2022, 3,308 people were killed and an estimated additional 289,310 people were injured in crashes involving distracted drivers. Therefore, the rise in trauma and accident cases is driving the growth of the blood plasma derivatives industry.

What Is Driving The Blood Plasma Derivatives Market? Rising Hemophilia Prevalence Ignites Growth In The Blood Plasma Derivatives Market

The increasing prevalence of hemophilia is expected to drive the growth of the blood plasma derivatives market. Hemophilia refers to a bleeding problem that is hereditary and causes the blood to not clot properly. This may result in both spontaneous bleeding and bleeding after injury or surgery. In people with hereditary or acquired problems with hemostasis, blood plasma-derived products or medications can effectively improve hemostasis. Treatment for hemophilia A, von Willebrand disease, and hemophilia B uses factor VIII, factor VIII/vWF, and factor IX concentrates, respectively. For instance, in August 2022, according to the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, there were 3.7 cases of hemophilia B and 12 cases of hemophilia A per 100,000 American males in the country, respectively. Moreover, it affects 1 in 5,617 male births in the United States and 1 in 19,283 male births with hemophilia B. Therefore, the increasing prevalence of hemophilia is driving the growth of the blood plasma derivatives industry.

Who Are The Major Players In The Global Blood Plasma Derivatives Market?

Major companies operating in the blood plasma derivatives market include Bayer AG, Sanofi S.A., Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Limited, Meiji Group, Grifols S.A., Shire Pharmaceuticals Inc., GC Biopharma Corp, Emergent BioSolutions Inc., Shanghai Raas Blood Products Co Ltd., Kedrion S.p.A., Sanquin, Biotest AG, Bio Products Ltd., ADMA Biologics Inc., China Biologic Products Holdings Inc., BioIVT, PlasmaGen BioSciences Pvt. Ltd., Virchow Biotech Private Limited, LFB S.A., Intas Pharmaceuticals Ltd., Octapharma Plasma

What Are The Key Trends Of The Global Blood Plasma Derivatives Market? Strategic Partnerships In The Blood Plasma Derivatives Market For Enhancing Access And Supply For Immunoglobulins In France And Beyond

Major companies operating in the blood plasma derivatives market are focused on adopting strategic partnerships to gain a competitive edge in the market. With this partnership, patients in need will have access to a steady and dependable supply of these vital plasma-derived medications, helping to meet the increasing need for immunoglobulins in France and beyond. For instance, in January 2022, Kedrion S.p.A. an Italy-based biopharmaceutical company specializing in the development, production, and distribution of plasma-derived therapies partnered with LPB, a UK-based pharmaceutical company specializing in biological medicinal products. Kedrion will use LFB plasma obtained in France by the Etablissement Français du Sang (EFS) to produce immunoglobulins in Hungary. The current supply of immunoglobulins, which will be made available to hospitals across the nation in accordance with and under the supervision of French health authorities, will be supplemented by these imports from LFB in France.

Need data on a specific region in this market?
Request Customisation

Blood Plasma Derivatives Market Merger And Acquisition: Grifols S.A. Enhances Plasma Medicine Availability And Expands Product Line With Acquisition Of Biotest Ag

In April 2022, Grifols S.A., a Spain-based producer of plasma-derived medicines, acquired Biotest AG for an undisclosed amount. The acquisition of Biotest AG allows Grifols to improve the availability of plasma medicines for patients, accelerate and expand its product line, own the most extensive private European network of plasma facilities with 87 locations, and drive revenue growth and profitability expansion. Biotest AG is a Germany-based producer of several human blood plasma-derived concentrates for intensive care medicines.

Regional Outlook For The Global Blood Plasma Derivatives Market

North America was the largest region in the blood plasma derivatives market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Blood Plasma Derivatives Market?

The blood plasma derivatives market consists of sales of fibrinogen, globulin, sodium, potassium, bicarbonate, and chloride. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Blood Plasma Derivatives Industry?

The blood plasma derivatives market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the blood plasma derivatives industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Blood Plasma Derivatives Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $55.76 billion
Revenue Forecast In 2034 $79.09 billion
Growth Rate CAGR of 9.1% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Other Types
2) By Application: Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand's Disease, Other Applications
3) By End-User: Hospitals, Clinics, Other End-Users Subsegments: 1) By Albumin: Human Serum Albumin, Recombinant Albumin
2) By Factor VIII: Plasma-Derived Factor VIII, Recombinant Factor VIII
3) By Factor IX: Plasma-Derived Factor IX, Recombinant Factor IX
4) By Immunoglobulin: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)
5) By Hyperimmune Globulin: Specific Pathogen-Reduced Hyperimmune Globulin, Standard Hyperimmune Globulin 6) By Other Types: Fibrinogen, Clotting Factor Concentrates, Plasma-Derived Proteins
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Bayer AG, Sanofi S.A., Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Limited, Meiji Group, Grifols S.A., Shire Pharmaceuticals Inc., GC Biopharma Corp, Emergent BioSolutions Inc., Shanghai Raas Blood Products Co Ltd., Kedrion S.p.A., Sanquin, Biotest AG, Bio Products Ltd., ADMA Biologics Inc., China Biologic Products Holdings Inc., BioIVT, PlasmaGen BioSciences Pvt. Ltd., Virchow Biotech Private Limited, LFB S.A., Intas Pharmaceuticals Ltd., Octapharma Plasma
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Blood Plasma Derivatives Market Characteristics

3. Blood Plasma Derivatives Market Trends And Strategies

4. Blood Plasma Derivatives Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Blood Plasma Derivatives Growth Analysis And Strategic Analysis Framework

5.1. Global Blood Plasma Derivatives PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Blood Plasma Derivatives Market Growth Rate Analysis

5.4. Global Blood Plasma Derivatives Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Blood Plasma Derivatives Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Blood Plasma Derivatives Total Addressable Market (TAM)

6. Blood Plasma Derivatives Market Segmentation

6.1. Global Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Albumin

Factor VIII

Factor IX

Immunoglobulin

Hyperimmune Globulin

Other Types

6.2. Global Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hemophilia

Hypogammaglobulinemia

Immunodeficiency Diseases

Von Willebrand's Disease

Other Applications

6.3. Global Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinics

Other End-Users

6.4. Global Blood Plasma Derivatives Market, Sub-Segmentation Of Albumin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Human Serum Albumin

Recombinant Albumin

6.5. Global Blood Plasma Derivatives Market, Sub-Segmentation Of Factor VIII, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Plasma-Derived Factor VIII

Recombinant Factor VIII

6.6. Global Blood Plasma Derivatives Market, Sub-Segmentation Of Factor IX, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Plasma-Derived Factor IX

Recombinant Factor IX

6.7. Global Blood Plasma Derivatives Market, Sub-Segmentation Of Immunoglobulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Intravenous Immunoglobulin (IVIG)

Subcutaneous Immunoglobulin (SCIG)

6.8. Global Blood Plasma Derivatives Market, Sub-Segmentation Of Hyperimmune Globulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Specific Pathogen-Reduced Hyperimmune Globulin

Standard Hyperimmune Globulin

6.9. Global Blood Plasma Derivatives Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Fibrinogen

Clotting Factor Concentrates

Plasma-Derived Proteins

7. Blood Plasma Derivatives Market Regional And Country Analysis

7.1. Global Blood Plasma Derivatives Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Blood Plasma Derivatives Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Blood Plasma Derivatives Market

8.1. Asia-Pacific Blood Plasma Derivatives Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Blood Plasma Derivatives Market

9.1. China Blood Plasma Derivatives Market Overview

9.2. China Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Blood Plasma Derivatives Market

10.1. India Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Blood Plasma Derivatives Market

11.1. Japan Blood Plasma Derivatives Market Overview

11.2. Japan Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Blood Plasma Derivatives Market

12.1. Australia Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Blood Plasma Derivatives Market

13.1. Indonesia Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Blood Plasma Derivatives Market

14.1. South Korea Blood Plasma Derivatives Market Overview

14.2. South Korea Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Blood Plasma Derivatives Market

15.1. Western Europe Blood Plasma Derivatives Market Overview

15.2. Western Europe Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Blood Plasma Derivatives Market

16.1. UK Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Blood Plasma Derivatives Market

17.1. Germany Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Blood Plasma Derivatives Market

18.1. France Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Blood Plasma Derivatives Market

19.1. Italy Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Blood Plasma Derivatives Market

20.1. Spain Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Blood Plasma Derivatives Market

21.1. Eastern Europe Blood Plasma Derivatives Market Overview

21.2. Eastern Europe Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Blood Plasma Derivatives Market

22.1. Russia Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Blood Plasma Derivatives Market

23.1. North America Blood Plasma Derivatives Market Overview

23.2. North America Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Blood Plasma Derivatives Market

24.1. USA Blood Plasma Derivatives Market Overview

24.2. USA Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Blood Plasma Derivatives Market

25.1. Canada Blood Plasma Derivatives Market Overview

25.2. Canada Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Blood Plasma Derivatives Market

26.1. South America Blood Plasma Derivatives Market Overview

26.2. South America Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Blood Plasma Derivatives Market

27.1. Brazil Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Blood Plasma Derivatives Market

28.1. Middle East Blood Plasma Derivatives Market Overview

28.2. Middle East Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Blood Plasma Derivatives Market

29.1. Africa Blood Plasma Derivatives Market Overview

29.2. Africa Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Blood Plasma Derivatives Market Competitive Landscape And Company Profiles

30.1. Blood Plasma Derivatives Market Competitive Landscape

30.2. Blood Plasma Derivatives Market Company Profiles

30.2.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. CSL Limited Overview, Products and Services, Strategy and Financial Analysis

31. Blood Plasma Derivatives Market Other Major And Innovative Companies

31.1. Meiji Group

31.2. Grifols S.A.

31.3. Shire Pharmaceuticals Inc.

31.4. GC Biopharma Corp

31.5. Emergent BioSolutions Inc.

31.6. Shanghai Raas Blood Products Co Ltd.

31.7. Kedrion S.p.A.

31.8. Sanquin

31.9. Biotest AG

31.10. Bio Products Ltd.

31.11. ADMA Biologics Inc.

31.12. China Biologic Products Holdings Inc.

31.13. BioIVT

31.14. PlasmaGen BioSciences Pvt. Ltd.

31.15. Virchow Biotech Private Limited

32. Global Blood Plasma Derivatives Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Blood Plasma Derivatives Market

34. Recent Developments In The Blood Plasma Derivatives Market

35. Blood Plasma Derivatives Market High Potential Countries, Segments and Strategies

35.1 Blood Plasma Derivatives Market In 2029 - Countries Offering Most New Opportunities

35.2 Blood Plasma Derivatives Market In 2029 - Segments Offering Most New Opportunities

35.3 Blood Plasma Derivatives Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Blood Plasma Derivatives Market, Sub-Segmentation Of Albumin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Blood Plasma Derivatives Market, Sub-Segmentation Of Factor VIII, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Blood Plasma Derivatives Market, Sub-Segmentation Of Factor IX, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Blood Plasma Derivatives Market, Sub-Segmentation Of Immunoglobulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Blood Plasma Derivatives Market, Sub-Segmentation Of Hyperimmune Globulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Blood Plasma Derivatives Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Blood Plasma Derivatives Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Blood Plasma Derivatives Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Bayer AG Financial Performance
  • Table 81: Sanofi S.A. Financial Performance
  • Table 82: Takeda Pharmaceutical Company Limited Financial Performance
  • Table 83: Baxter International Inc. Financial Performance
  • Table 84: CSL Limited Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Blood Plasma Derivatives Market, Sub-Segmentation Of Albumin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Blood Plasma Derivatives Market, Sub-Segmentation Of Factor VIII, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Blood Plasma Derivatives Market, Sub-Segmentation Of Factor IX, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Blood Plasma Derivatives Market, Sub-Segmentation Of Immunoglobulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Blood Plasma Derivatives Market, Sub-Segmentation Of Hyperimmune Globulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Blood Plasma Derivatives Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Blood Plasma Derivatives Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Blood Plasma Derivatives Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Blood Plasma Derivatives Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Blood Plasma Derivatives Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Blood Plasma Derivatives Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Bayer AG Financial Performance
  • Figure 81: Sanofi S.A. Financial Performance
  • Figure 82: Takeda Pharmaceutical Company Limited Financial Performance
  • Figure 83: Baxter International Inc. Financial Performance
  • Figure 84: CSL Limited Financial Performance

Strategic Growth Drivers Shaping the Nutraceutical Excipients Market Outlook 2025- 2034:The Role Of Health And Wellness In Driving Growth In The Nutraceutical Excipients Market

Read More About Strategic Growth Drivers Shaping the Nutraceutical Excipients Market Outlook 2025- 2034:The Role Of Health And Wellness In Driving Growth In The Nutraceutical Excipients Market

Emerging Growth Drivers in the Opioids Market Landscape: Growing Surgical Procedures Fueling Demand In The Opioids Market

Read More About Emerging Growth Drivers in the Opioids Market Landscape: Growing Surgical Procedures Fueling Demand In The Opioids Market

Osimertinib Drugs Market Outlook 2025–2034: Identifying Growth Drivers, Technology Trends, and Policy Impact

Read More About Osimertinib Drugs Market Outlook 2025–2034: Identifying Growth Drivers, Technology Trends, and Policy Impact

Otic Drugs Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

Read More About Otic Drugs Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Read More About A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Read More About A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Electric Ships Market 2024 – By Type (Fully Electric, Hybrid), By Mode Of Operation (Manned, Remotely Operated, Autonomous), By System (Energy Storage Systems, Power Conversion, Power Generation, Power Distribution), By...

View Report

Pharmaceutical Pellets Market 2024 – By Technology (Extrusion, Fluid Bed Granulation, Dry Powder Layering, Solution And Suspension Layering, Spray Congealing, Spray Drying, Other Technologies), By Mechanism Of Action (Di...

View Report

Customized Premixes Global Market Report 2025 – By Nutrient (Vitamins, Minerals, Amino Acids, Nucleotides, Nutraceuticals, Other Nutrients), By Form (Powder, Liquid), By Application (Beverages, Dairy, Cereals, Bakery and...

View Report

Convalescent Plasma Therapy Global Market Report 2025 – By Antibody type (IgM, IgG, IgA), By Application (Prophylaxis, Treatment), By End-Users (Hospitals & Clinics, Laboratories & Research institutes) – Impact of Tariff...

View Report

Bathroom Products Global Market Report 2025 – By Type (Bathroom Basin, Bathroom Furniture, Bathroom Accessories), By Distribution Channel (Online, Offline), By Application (Residential, Commercial, Institutional, Other A...

View Report

Human Resources (HR) Transformation Consulting Global Market Report 2025 – By Type (Human Resource Technology Strategy, Human Resource Architecture And Change Management, Human Resource Vendor And Software Selection, Oth...

View Report

Life Science And Chemical Instrumentation Global Market Report 2025 – By Technology( Polymerase Chain Reaction (PCR), DNA Sequencers and Amplifiers, Flow Cytometry, Spectroscopy, Electrophoresis, Chromatography, Centrifu...

View Report

WiGig Global Market Report 2025 – By Product (Display Devices, Network Infrastructure Devices), By Technology Type (System-on-Chip (SoC), Integrated Circuit Chip (IC)), By Enterprise Size (Large Enterprises, Small And Me...

View Report

Frequently Asked Questions

Blood plasma derivatives are medicinal products crafted from refined proteins found in blood plasma, encompassing clotting factors, albumins, and other proteins employed to treat diverse medical ailments. These derivatives hold significant significance as they aid in replenishing absent or inadequate proteins within the body. For further insights on this market, request a sample here

The market major growth driver - Surging Demand For Blood Plasma Derivatives Driven By The Increasing Prevalence Of Immune Deficiency Disorders. For further insights on this market, request a sample here

The blood plasma derivatives market size has grown strongly in recent years. It will grow from $51.81 billion in 2024 to $55.76 billion in 2025 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to increased prevalence of hemophilia and bleeding disorders, growth in geriatric population, increased awareness and diagnosis, rise in surgical procedures, global blood transfusion services. The blood plasma derivatives market size is expected to see strong growth in the next few years. It will grow to " $79.09 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to emergence of rare diseases therapies, growth in chronic diseases, increasing healthcare expenditure, patient-centric treatment approaches, growing healthcare infrastructure. Major trends in the forecast period include advancements in fractionation technologies, patient-centric approaches, collaborations and partnerships, expanding applications in neurology, technological innovations in plasma fractionation. For further insights on this market, request a sample here

The blood plasma derivativesmarket covered in this report is segmented –
1) By Type: Albumin; Factor VIII; Factor IX; Immunoglobulin; Hyperimmune Globulin; Other Types
2) By Application: Hemophilia; Hypogammaglobulinemia; Immunodeficiency Diseases; Von Willebrand's Disease; Other Applications
3) By End-User: Hospitals; Clinics; Other End-Users Subsegments:
1) By Albumin: Human Serum Albumin; Recombinant Albumin
2) By Factor VIII: Plasma-Derived Factor VIII; Recombinant Factor VIII
3) By Factor IX: Plasma-Derived Factor IX; Recombinant Factor IX
4) By Immunoglobulin: Intravenous Immunoglobulin (IVIG); Subcutaneous Immunoglobulin (SCIG)
5) By Hyperimmune Globulin: Specific Pathogen-Reduced Hyperimmune Globulin; Standard Hyperimmune Globulin
6) By Other Types: Fibrinogen; Clotting Factor Concentrates; Plasma-Derived Proteins For further insights on this market, request a sample here

North America was the largest region in the blood plasma derivatives market in 2024. The regions covered in the blood plasma derivatives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the blood plasma derivatives market include Bayer AG, Sanofi S.A., Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Limited, Meiji Group, Grifols S.A., Shire Pharmaceuticals Inc., GC Biopharma Corp, Emergent BioSolutions Inc., Shanghai Raas Blood Products Co Ltd., Kedrion S.p.A., Sanquin, Biotest AG, Bio Products Ltd., ADMA Biologics Inc., China Biologic Products Holdings Inc., BioIVT, PlasmaGen BioSciences Pvt. Ltd., Virchow Biotech Private Limited, LFB S.A., Intas Pharmaceuticals Ltd., Octapharma Plasma . For further insights on this market, request a sample here.

Major trends in this market include Strategic Partnerships In The Blood Plasma Derivatives Market For Enhancing Access And Supply For Immunoglobulins In France And Beyond. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Blood Plasma Derivatives Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon